# ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

> **NCT01382797** · PHASE2 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 157 (actual)

## Conditions studied

- Opioid-induced Constipation

## Interventions

- **DRUG:** ALKS 37
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01382797
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382797, "ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01382797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*